NGL Fine-Chem DuPont analysis

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.75×0.76×0.76×0.76×0.75×
1.19×1.19×1.29×1.31×1.19×
11.9%10.6%5.8%12.3%8.3%
1.02×1.02×0.93×1.05×0.97×
1.66×1.66×1.53×1.35×1.29×
18.0%16.2%8.2%17.3%9.2%
15.7%15.7%7.8%17.0%9.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NGLFINE₹2,612.80

NGL Fine-Chem Limited

· Pharma & Health
₹ CrorePeersSYNCOMFJAGSNPHARMHESTERBIOAMRUTANJANWINDLASINDOCOSAIPARENTMcap ₹1,614 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.750.760.760.760.75
Interest Burden (Pretax/EBIT) ×1.191.311.291.191.19
EBIT Margin %8.2812.295.8210.6011.86
Asset Turnover ×0.971.050.931.021.02
Financial Leverage (Assets/Equity) ×1.291.351.531.661.66
ROE (5-step product, year-end total equity) %9.2217.348.1916.2418.03
ROE (owners' profit / average owners' equity) %9.2117.037.7515.7415.74
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.